骨科环境中的骨折预防:基于协调员的骨折联络服务结局
本研究描述加拿大一家城市大学创伤医院的基于协调员的骨折联络服务中,未接受过药物治疗的脆性骨折患者的骨密度检测、医师评估和药物治疗启动等关键临床结局。2191例患者中,住院患者84%、门诊患者85%完成了推荐的骨密度检测;转诊进行骨骼健康管理的患者中,住院85%、门诊79%接受了专科或初级保健医师评估;就诊患者中,住院73%、门诊52%获得了抗骨质疏松药物处方。结论认为通过协调员促进的骨折联络服务项目可以实现高比例的教育、评估和药物治疗(如有指征)。
要点
- 2191例脆性骨折患者(住院862例,门诊1329例)在识别时均未接受抗骨质疏松药物治疗。
- 住院患者84%、门诊患者85%完成了推荐的骨密度检测。
- 转诊进行骨骼健康管理的患者中,住院85%、门诊79%接受了专科或初级保健医师评估。
核心结论
- 通过协调员促进的骨折联络服务项目,可以实现高比例的教育、评估和药物治疗(如有指征)。
研究设计与样本
- 研究描述了加拿大一家城市大学创伤医院的基于协调员的骨折联络服务中,因脆性骨折接受治疗的未接受过药物治疗的住院和门诊患者的骨折后检查和治疗率。
- 项目识别年龄≥40岁女性患者和年龄≥50岁男性患者的桡骨远端、股骨近端、肱骨近端和椎体脆性骨折,并提供教育、骨密度检测、住院会诊或门诊专科或初级保健医师转诊进行骨骼健康管理,以及记录患者随访。
主要发现
- 2191例脆性骨折患者在识别时未接受抗骨质疏松药物治疗(住院862例,门诊1329例)。
- 住院患者84%和门诊患者85%完成了推荐的骨密度检测。
- 基于股骨颈或L1至L4的骨密度T值≤-2.5确认骨质疏松:股骨近端骨折患者52%,椎体骨折患者29%,肱骨近端骨折患者26%,桡骨远端骨折患者20%。
- 转诊进行骨骼健康管理的住院患者85%和门诊患者79%接受了专科或初级保健医师评估。
- 在就诊的患者中,住院患者73%和门诊患者52%获得了抗骨质疏松药物处方。
关键数值与推荐
- 骨质疏松确认标准为股骨颈或L1至L4的骨密度T值≤-2.5。
- 项目识别标准为女性患者≥40岁和男性患者≥50岁的桡骨远端、股骨近端、肱骨近端和椎体脆性骨折。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fracture liaison services focus on secondary fracture prevention by identifying patients at risk for future fracture and initiating appropriate evaluation, risk assessment, education, and therapeutic intervention. This study describes key clinical outcomes including bone mineral densitometry, physician assessment, and pharmacotherapy initiation in pharmacotherapy-naïve patients undergoing treatment for fragility fracture in a Canadian fracture liaison service. METHODS: We determined rates of post-fracture investigation and treatment for inpatients and outpatients with a fragility fracture seen in a coordinator-based fracture liaison service at an urban university trauma hospital. The program identified distal radial, proximal femoral, proximal humeral, and vertebral fragility fractures in female patients ≥40 years of age and male patients ≥50 years of age and provided education, bone mineral densitometry, inpatient consultation or outpatient specialist or primary care physician referral for bone health management, and documented patient follow-up. RESULTS: The 2,191 patients with a fragility fracture were not taking anti-osteoporosis pharmacotherapy at the time of identification (862 inpatients and 1,329 outpatients). Eighty-four percent of inpatients and 85% of outpatients completed a bone mineral densitometry as recommended. Fifty-two percent of patients with proximal femoral fracture, 29% of patients with vertebral fracture, 26% of patients with proximal humeral fracture, and 20% of patients with distal radial fracture had osteoporosis confirmed on the basis of a bone mineral densitometry T-score of ≤-2.5 at the femoral neck or L1 to L4. Eighty-five percent of inpatients and 79% of outpatients referred for bone health management were assessed by a specialist or primary care physician. Of the patients who attended their appointments, 73% of inpatients and 52% of outpatients received a prescription for anti-osteoporosis medication. CONCLUSIONS: A high rate of education, evaluation, and pharmacological treatment, if indicated, can be achieved through a coordinator-facilitated fracture liaison service program. CLINICAL RELEVANCE: Fracture prevention programs are currently engaged in establishing and modifying fracture liaison services in a quest for practical and effective models. The program described in this article exemplifies a coordinator-based model that produced good outcomes.
引用
- Bogoch ER, Elliot-Gibson V, Beaton D, et al. Fracture Prevention in the Orthopaedic Environment: Outcomes of a Coordinator-Based Fracture Liaison Service. J Bone Joint Surg Am. 2017. PMID: 28509822. doi:10.2106/JBJS.16.01042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。